Film-coated tablet: Moxifloxacin is contraindicated in patients: With hypersensitivity to moxifloxacin or other quinolones and any components of this medication.
Less than 18 years of age.
Pregnancy and lactation.
With history of tendon disease/disorder related to quinolone treatment.
With impaired liver function and in patients with transaminases > 5 fold ULN.
With congenital or documented acquired QT prolongation.
With electrolyte disturbances, particularly in uncorrected hypokalaemia.
With clinically relevant bradycardia.
With clinically relevant heart failure with reduced left ventricular ejection fraction.
With previous history of symptomatic arrhythmias.
Solution for injection: Moxifloxacin is contraindicated in: Patients with a history of hypersensitivity to moxifloxacin or any member of the quinolones class of antimicrobial agents.
Pediatric patients, adolescents (less than 18 years of age).
Pregnant and lactating women.
Moxifloxacin should be avoided in patients with known prolongation of the QT interval, with uncorrected hypokalemia and patients receiving Class IA (quinidine, procainamide) and Class III (amiodarone, sotalol) antiarrhythmic agents.
Other Services
Country
Account